Research Solutions (RSSS)
Market Price (5/25/2026): $2.25 | Market Cap: $72.0 MilSector: Consumer Staples | Industry: Tobacco
Research Solutions (RSSS)
Market Price (5/25/2026): $2.25Market Cap: $72.0 MilSector: Consumer StaplesIndustry: Tobacco
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 6.3%, FCF Yield is 7.9% Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -17% Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 12%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 12% Low stock price volatilityVol 12M is 48% Megatrend and thematic driversMegatrends include Research & Information Management, Cloud Computing, and Artificial Intelligence. Themes include Scholarly Content Automation, Show more. | Weak multi-year price returns2Y Excs Rtn is -60%, 3Y Excs Rtn is -73% | Weak revenue growthRev Chg QQuarterly Revenue Change % is -4.3% Key risksRSSS key risks include [1] weakening transaction revenue due to a decline in spending from large customers, Show more. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 6.3%, FCF Yield is 7.9% |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -17% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 12%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 12% |
| Low stock price volatilityVol 12M is 48% |
| Megatrend and thematic driversMegatrends include Research & Information Management, Cloud Computing, and Artificial Intelligence. Themes include Scholarly Content Automation, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -60%, 3Y Excs Rtn is -73% |
| Weak revenue growthRev Chg QQuarterly Revenue Change % is -4.3% |
| Key risksRSSS key risks include [1] weakening transaction revenue due to a decline in spending from large customers, Show more. |
Qualitative Assessment
AI Analysis | Feedback
1. Weaker than Expected Q2 Fiscal Year 2026 Earnings.
On February 12, 2026, Research Solutions reported earnings per share (EPS) of $0.02 for the second quarter of fiscal year 2026, missing the analyst consensus estimate of $0.03. Additionally, revenue for the quarter was $11.79 million, falling short of analyst estimates of $12.16 million.
2. Q3 Fiscal Year 2026 Revenue and EPS Misses.
The company announced its Q3 Fiscal Year 2026 results on May 14, 2026, reporting an EPS of $0.03, which missed the Zacks Consensus Estimate of $0.04. Total revenue for the quarter was $12.12 million, also below the consensus estimate of $12.37 million. This announcement led to an 11.81% decline in RSSS stock on the day it was published.
Show more
Stock Movement Drivers
Fundamental Drivers
The -21.1% change in RSSS stock from 1/31/2026 to 5/24/2026 was primarily driven by a -75.9% change in the company's P/E Multiple.| (LTM values as of) | 1312026 | 5242026 | Change |
|---|---|---|---|
| Stock Price ($) | 2.85 | 2.25 | -21.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 49 | 49 | -1.3% |
| Net Income Margin (%) | 2.7% | 9.3% | 240.2% |
| P/E Multiple | 66.1 | 15.9 | -75.9% |
| Shares Outstanding (Mil) | 31 | 32 | -2.4% |
| Cumulative Contribution | -21.1% |
Market Drivers
1/31/2026 to 5/24/2026| Return | Correlation | |
|---|---|---|
| RSSS | -21.1% | |
| Market (SPY) | 8.1% | 23.8% |
| Sector (XLP) | 2.1% | 2.7% |
Fundamental Drivers
The -30.6% change in RSSS stock from 10/31/2025 to 5/24/2026 was primarily driven by a -79.9% change in the company's P/E Multiple.| (LTM values as of) | 10312025 | 5242026 | Change |
|---|---|---|---|
| Stock Price ($) | 3.24 | 2.25 | -30.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 49 | 49 | -0.8% |
| Net Income Margin (%) | 2.6% | 9.3% | 259.8% |
| P/E Multiple | 79.2 | 15.9 | -79.9% |
| Shares Outstanding (Mil) | 31 | 32 | -3.3% |
| Cumulative Contribution | -30.6% |
Market Drivers
10/31/2025 to 5/24/2026| Return | Correlation | |
|---|---|---|
| RSSS | -30.6% | |
| Market (SPY) | 9.9% | 21.1% |
| Sector (XLP) | 12.7% | 14.8% |
Fundamental Drivers
The -17.9% change in RSSS stock from 4/30/2025 to 5/24/2026 was primarily driven by a -14.4% change in the company's P/S Multiple.| (LTM values as of) | 4302025 | 5242026 | Change |
|---|---|---|---|
| Stock Price ($) | 2.74 | 2.25 | -17.9% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 48 | 49 | 0.9% |
| P/S Multiple | 1.7 | 1.5 | -14.4% |
| Shares Outstanding (Mil) | 30 | 32 | -4.9% |
| Cumulative Contribution | -17.9% |
Market Drivers
4/30/2025 to 5/24/2026| Return | Correlation | |
|---|---|---|
| RSSS | -17.9% | |
| Market (SPY) | 36.0% | 18.2% |
| Sector (XLP) | 6.5% | 6.0% |
Fundamental Drivers
The 5.6% change in RSSS stock from 4/30/2023 to 5/24/2026 was primarily driven by a 40.2% change in the company's Total Revenues ($ Mil).| (LTM values as of) | 4302023 | 5242026 | Change |
|---|---|---|---|
| Stock Price ($) | 2.13 | 2.25 | 5.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 35 | 49 | 40.2% |
| P/S Multiple | 1.6 | 1.5 | -10.1% |
| Shares Outstanding (Mil) | 27 | 32 | -16.2% |
| Cumulative Contribution | 5.6% |
Market Drivers
4/30/2023 to 5/24/2026| Return | Correlation | |
|---|---|---|
| RSSS | 5.6% | |
| Market (SPY) | 86.3% | 10.6% |
| Sector (XLP) | 18.8% | 1.2% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| RSSS Return | 6% | -22% | 35% | 60% | -29% | -23% | -3% |
| Peers Return | -21% | -65% | 11% | -45% | -34% | -28% | -92% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 9% | 98% |
Monthly Win Rates [3] | |||||||
| RSSS Win Rate | 42% | 42% | 58% | 50% | 42% | 20% | |
| Peers Win Rate | 50% | 25% | 33% | 33% | 42% | 40% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 60% | |
Max Drawdowns [4] | |||||||
| RSSS Max Drawdown | -31% | -29% | -16% | -30% | -43% | -29% | |
| Peers Max Drawdown | -38% | -67% | -47% | -54% | -45% | -52% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: CLVT.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 5/22/2026 (YTD)
How Low Can It Go
| Event | RSSS | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -28.0% | -18.8% |
| % Gain to Breakeven | 39.0% | 23.1% |
| Time to Breakeven | 145 days | 79 days |
| 2023 SVB Regional Banking Crisis | ||
| % Loss | -16.3% | -6.7% |
| % Gain to Breakeven | 19.5% | 7.1% |
| Time to Breakeven | 85 days | 31 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -25.8% | -24.5% |
| % Gain to Breakeven | 34.8% | 32.4% |
| Time to Breakeven | 446 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -26.5% | -33.7% |
| % Gain to Breakeven | 36.0% | 50.9% |
| Time to Breakeven | 1447 days | 140 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -60.7% | -17.9% |
| % Gain to Breakeven | 154.3% | 21.8% |
| Time to Breakeven | 2940 days | 123 days |
In The Past
Research Solutions's stock fell -28.0% during the 2025 US Tariff Shock. Such a loss loss requires a 39.0% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | RSSS | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -28.0% | -18.8% |
| % Gain to Breakeven | 39.0% | 23.1% |
| Time to Breakeven | 145 days | 79 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -25.8% | -24.5% |
| % Gain to Breakeven | 34.8% | 32.4% |
| Time to Breakeven | 446 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -26.5% | -33.7% |
| % Gain to Breakeven | 36.0% | 50.9% |
| Time to Breakeven | 1447 days | 140 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -60.7% | -17.9% |
| % Gain to Breakeven | 154.3% | 21.8% |
| Time to Breakeven | 2940 days | 123 days |
In The Past
Research Solutions's stock fell -28.0% during the 2025 US Tariff Shock. Such a loss loss requires a 39.0% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Research Solutions (RSSS)
AI Analysis | Feedback
Here are 1-3 brief analogies for Research Solutions (RSSS):
- Amazon for scientific articles: It provides a platform for the transactional sale and delivery of scientific, technical, and medical (STM) content, similar to how Amazon is a go-to source for a vast array of goods.
- LexisNexis for scientific research: Like LexisNexis provides a comprehensive database and tools for legal professionals to access and manage legal documents, RSSS offers a specialized platform for researchers to access and manage STM articles.
- A Bloomberg Terminal for scientific research: It functions as a specialized, comprehensive platform for research-intensive organizations to access and manage critical scientific information, much like the Bloomberg Terminal provides essential financial data and tools to financial professionals.
AI Analysis | Feedback
- Cloud-based SaaS Research Platform: This platform helps research organizations accelerate their R&D by providing access to and management of scientific, technical, and medical (STM) articles.
- Transactional STM Content Sales: This service facilitates the acquisition of published scientific, technical, and medical (STM) content through managed sourcing and delivery.
AI Analysis | Feedback
Research Solutions (RSSS) primarily sells its cloud-based software-as-a-service research platform and scientific, technical, and medical (STM) content to other companies and research institutions.
According to the company's public filings, no single customer accounted for 10% or more of its consolidated revenues during recent fiscal years. Therefore, Research Solutions does not have individually named "major customers" that contribute a disproportionately large share of revenue.
However, the company serves a diverse range of research-intensive organizations across various sectors. Its customer base primarily consists of organizations that require access to STM content for their research and development activities. These categories of customer organizations include:
- Pharmaceutical companies
- Biotechnology companies
- Universities and academic institutions
- Medical device companies
- Other organizations engaged in scientific, technical, and medical (STM) research and development activities.
AI Analysis | Feedback
nullAI Analysis | Feedback
Roy W. Olivier - Chairman, President, and Chief Executive Officer
Roy W. Olivier joined Research Solutions' board of directors in January 2018, becoming Interim CEO on March 29, 2021, permanent CEO on October 4, 2021, and was appointed Chairman on September 16, 2025. Prior to his time at Research Solutions, he served as CEO of ARI Network Services, where he was instrumental in growing the business from under 80 employees to over 1,200 and increasing revenues from less than $15 million to over $100 million through a combination of organic growth and acquisitions. He also founded ProQuest Media Solutions (now Snap-on Inc.) in 1993, a business he later sold to ProQuest in 2000.
Dave Kutil - Interim Chief Financial Officer and Secretary
Dave Kutil was appointed interim Chief Financial Officer and Secretary of Research Solutions, effective December 10, 2025, following the departure of Bill Nurthen. He joined Research Solutions in 2023 as Controller and brings over 15 years of financial leadership experience to the role. Before joining Research Solutions, Kutil served as Controller for the North American subsidiary of Lesaffre and as Director of Accounting for Badger Meter.
Sefton Cohen - Chief Revenue Officer
Sefton Cohen was appointed Chief Revenue Officer of Research Solutions on November 19, 2024. He possesses over two decades of experience in scaling high-growth SaaS companies. Prior to joining Research Solutions, he held the position of CRO at Suralink and RapidRatings, where he notably led a commercial transformation that resulted in a $240 million private equity exit.
Rick Salloum - Chief Technology Officer
Rick Salloum was appointed Chief Technology Officer of Research Solutions on April 3, 2023. He has nearly three decades of extensive technology experience, having worked with both publicly traded and private equity organizations. Before his role at Research Solutions, Salloum served as the Vice President of Software Development and Technology Solutions at Safe-Guard Products. His previous executive technology leadership positions include Head of Engineering and Vice President of Engineering & Architecture for organizations such as Rent.com and CNN.com.
Peter Derycz - Founder
Peter Derycz founded Research Solutions (originally known as Reprints Desk) in 2006. He previously served as President and Chief Executive Officer of the company. Derycz transitioned to Executive Chairman and Chairman of the Board effective March 29, 2021. He is recognized for his over 20 years of involvement in designing, developing, and deploying large library and document management systems, and is known as one of the founders of the "pay-as-you-go" approach to acquiring and delivering scientific information. However, his employment was terminated, and he resigned from the Company's board of directors and all committees effective September 18, 2023.
AI Analysis | Feedback
Key Business Risks for Research Solutions (RSSS)
- Impact of Artificial Intelligence on Research Workflows: A primary risk for Research Solutions is the evolving landscape of artificial intelligence. Management has noted that AI is "shifting demand from article retrieval to structured reasoning," which could significantly impact the company's transaction revenues. This suggests a fundamental change in how researchers seek and process scientific, technical, and medical (STM) content, potentially reducing reliance on traditional article retrieval services that form a component of Research Solutions' business model.
- Declining Transaction Revenue and Customer Base amid Competitive Pressures: Research Solutions faces persistent challenges with declining transaction revenue and a decrease in its active customer count. This decline is attributed to weaker paid order volume and competitive pressures within the B2C segment. The company itself anticipates that transaction revenue growth will remain challenging in the near term.
- Intense Competition from Established Publishers and Other Providers: Research Solutions operates in a highly competitive market for academic publishing and research solutions. The company faces competition from large, established players such as Elsevier, Springer Nature, and Wiley. This competitive environment, along with other companies in the business services sector, could exert pressure on pricing, market share, and the need for continuous innovation.
AI Analysis | Feedback
The clear emerging threat to Research Solutions (RSSS) is the rapid advancement and adoption of **Generative Artificial Intelligence (AI) and Large Language Models (LLMs)**. These technologies are increasingly capable of synthesizing, summarizing, and extracting specific insights from vast amounts of scientific, technical, and medical (STM) content. This directly threatens RSSS's core value proposition of providing a platform for content access and management, as AI-powered research assistants could offer alternative, potentially more efficient, and automated ways for researchers to discover, analyze, and interact with published literature, thereby diminishing the need for traditional content management platforms and transactional sales facilitated by RSSS.
AI Analysis | Feedback
Research Solutions (symbol: RSSS) operates in two primary markets: the transactional sale of scientific, technical, and medical (STM) content, and cloud-based software-as-a-service (SaaS) research platforms.
Transactional Sale of Scientific, Technical, and Medical (STM) Content
The global market for scientific, technical, and medical (STM) publishing, which includes the transactional sale of STM content, was valued at approximately $35.6 billion in 2024. This market is projected to grow to $52.1 billion by 2033. Other estimates place the global STM publishing market at over $26 billion annually, with projections for it to reach around $34.19 billion in 2026 and $45.61 billion by 2035. North America holds a significant share of this global market, accounting for approximately 38% in 2024.
Cloud-Based Software-as-a-Service Research Platform
While a precise global dollar value for the entire addressable market of "research-focused SaaS platforms" that cater to corporate, academic, government, and individual researchers is not readily available, relevant market segments and company insights provide an indication of its size.
The global academic software market, which includes cloud-based solutions for educational and research institutions, was valued at US$0.8 billion in 2021 and is anticipated to reach US$2.7 billion by 2031. Another estimate projects this market to grow from USD 1.00 billion in 2022 to USD 1.72 billion by 2030.
Research Solutions itself indicates that the "Research-focused SaaS is an under-penetrated market segment" and targets approximately 700,000 small and medium-sized businesses (SMBs) throughout the world, suggesting a large potential customer base.
AI Analysis | Feedback
```htmlResearch Solutions (RSSS) is expected to drive future revenue growth over the next 2-3 years through several key initiatives:
- Growth in Platform Subscription Revenue: The company has consistently reported increases in its platform subscription revenue, driven by both new deployments and expansion within its current customer base through upsells and cross-sells.
- Strategic Focus on B2B Market: Research Solutions is prioritizing B2B annual and multi-year agreements as a primary growth driver, with this segment showing strong annual recurring revenue (ARR) growth.
- API and AI Integration: The company is actively integrating API and AI capabilities, transitioning into an "answers and access" platform. This transformation is anticipated to lead to larger and more resilient contracts. An example of this is the launch of Scite MCP, which connects AI tools like ChatGPT and Claude to scientific literature.
- Expansion within Existing Customer Base: A significant portion of revenue growth is expected to come from deepening relationships with existing clients through upsells and cross-sells of additional services and expanded platform usage.
- Increase in Net New Platform Deployments: The acquisition of new platform customers and the resulting increase in platform deployments are direct contributors to the growth of platform subscription revenue.
AI Analysis | Feedback
Share Repurchases
- Research Solutions had a buyback yield of 0.52% on a trailing twelve-month basis as of December 31, 2025.
- The company's highest buyback yield over the past five years was 0.94% as of March 31, 2025.
- Net cash flow from issuance (purchase) of equity shares showed a purchase of approximately $430.55K as of December 31, 2025, and reached its highest purchase of $940.57K as of March 31, 2025, over the last five years.
Share Issuance
- In Q2 fiscal year 2026 (ended December 31, 2025), Research Solutions issued approximately 487,000 shares of stock as part of the scite earnout payments.
- In Q1 fiscal year 2026 (ended September 30, 2025), the company issued approximately 265,000 shares as part of the first payment for the scite earnout.
- As of December 31, 2025, Research Solutions had 32,875,476 shares issued and outstanding.
Outbound Investments
- Research Solutions acquired scite, an AI-powered search and discovery platform, in November 2023. This acquisition added $3.6 million in annualized software subscription revenue.
- In July 2023, Research Solutions acquired ResoluteAI, an advanced search platform leveraging AI and NLP technologies. The initial purchase consideration, net of cash acquired, was approximately $2.9 million, with a total purchase consideration of roughly $4.6 million, including a contingent earnout.
Capital Expenditures
- Research Solutions' capital expenditures to operating cash flow (CapEx/OCF) 3-year CAGR was -49.56% on a trailing twelve-month basis as of December 31, 2024.
- Over the past five years, the average CapEx/OCF 3-year CAGR for Research Solutions was 39%, with a high of 178.63% in September 2023.
- The company's strategy involves consistent reinvestments into organic growth and strategic M&A acquisitions, with profits reinvested to expand the AI & SaaS platform, improve user experience, and acquire more customers.
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| Research Solutions Earnings Notes | 12/16/2025 | |
| Research Solutions Stock Lost 12%, Buy Or Wait? | 10/17/2025 |
| Title | |
|---|---|
| ARTICLES |
Trade Ideas
Select ideas related to RSSS.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 04102026 | ELF | e.l.f. Beauty | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -1.8% | -1.8% | -6.2% |
| 04022026 | IPAR | Interparfums | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 0.7% | 0.7% | -0.3% |
| 04022026 | COKE | Coca-Cola Consolidated | Quality | Q | Momentum | UpsideQuality Stocks with Momentum and UpsideBuying quality stocks with strong momentum but still having room to run | 5.5% | 5.5% | -5.2% |
| 03272026 | MZTI | Marzetti | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -5.0% | -5.0% | -8.6% |
| 03272026 | TAP | Molson Coors Beverage | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -1.5% | -1.5% | -2.3% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 2.35 |
| Mkt Cap | 0.8 |
| Rev LTM | 1,248 |
| Op Inc LTM | 90 |
| FCF LTM | 170 |
| FCF 3Y Avg | 192 |
| CFO LTM | 299 |
| CFO 3Y Avg | 324 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | -1.7% |
| Rev Chg 3Y Avg | 4.1% |
| Rev Chg Q | -2.8% |
| QoQ Delta Rev Chg LTM | -0.7% |
| Op Inc Chg LTM | 44.4% |
| Op Inc Chg 3Y Avg | 27.4% |
| Op Mgn LTM | 7.6% |
| Op Mgn 3Y Avg | 5.9% |
| QoQ Delta Op Mgn LTM | 0.7% |
| CFO/Rev LTM | 18.0% |
| CFO/Rev 3Y Avg | 18.2% |
| FCF/Rev LTM | 12.7% |
| FCF/Rev 3Y Avg | 12.9% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 0.8 |
| P/S | 1.1 |
| P/Op Inc | 13.7 |
| P/EBIT | 12.2 |
| P/E | 2.3 |
| P/CFO | 7.6 |
| Total Yield | -1.2% |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | 10.4% |
| D/E | 1.4 |
| Net D/E | 1.2 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -5.0% |
| 3M Rtn | 15.1% |
| 6M Rtn | -27.9% |
| 12M Rtn | -30.4% |
| 3Y Rtn | -29.7% |
| 1M Excs Rtn | -11.1% |
| 3M Excs Rtn | 10.5% |
| 6M Excs Rtn | -33.1% |
| 12M Excs Rtn | -58.2% |
| 3Y Excs Rtn | -109.9% |
Price Behavior
| Market Price | $2.25 | |
| Market Cap ($ Bil) | 0.1 | |
| First Trading Date | 05/15/2009 | |
| Distance from 52W High | -43.2% | |
| 50 Days | 200 Days | |
| DMA Price | $2.42 | $2.85 |
| DMA Trend | down | indeterminate |
| Distance from DMA | -7.0% | -21.1% |
| 3M | 1YR | |
| Volatility | 54.1% | 48.2% |
| Downside Capture | 170.21 | 109.39 |
| Upside Capture | 88.39 | 47.76 |
| Correlation (SPY) | 25.4% | 18.5% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 1.18 | 0.65 | 0.61 | 0.73 | 0.63 | 0.32 |
| Up Beta | 0.88 | 0.91 | 0.99 | 1.22 | 0.79 | 0.16 |
| Down Beta | -2.20 | -1.09 | -0.45 | -0.01 | 0.51 | 0.32 |
| Up Capture | 123% | 100% | 35% | 30% | 32% | 15% |
| Bmk +ve Days | 15 | 22 | 31 | 66 | 141 | 428 |
| Stock +ve Days | 11 | 20 | 26 | 54 | 114 | 335 |
| Down Capture | 560% | 94% | 110% | 116% | 83% | 70% |
| Bmk -ve Days | 4 | 18 | 30 | 56 | 108 | 321 |
| Stock -ve Days | 9 | 18 | 30 | 59 | 116 | 356 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with RSSS | |
|---|---|---|---|---|
| RSSS | -19.4% | 48.1% | -0.30 | - |
| Sector ETF (XLP) | 6.8% | 12.4% | 0.25 | 4.6% |
| Equity (SPY) | 29.5% | 12.0% | 1.86 | 18.7% |
| Gold (GLD) | 35.5% | 26.8% | 1.11 | -4.6% |
| Commodities (DBC) | 42.9% | 18.7% | 1.77 | -11.9% |
| Real Estate (VNQ) | 15.2% | 13.1% | 0.82 | 11.7% |
| Bitcoin (BTCUSD) | -31.3% | 41.8% | -0.78 | 16.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with RSSS | |
|---|---|---|---|---|
| RSSS | 2.0% | 45.4% | 0.19 | - |
| Sector ETF (XLP) | 6.4% | 13.2% | 0.27 | 3.9% |
| Equity (SPY) | 14.0% | 17.0% | 0.64 | 11.6% |
| Gold (GLD) | 18.8% | 18.0% | 0.85 | -0.6% |
| Commodities (DBC) | 10.4% | 19.4% | 0.42 | 1.9% |
| Real Estate (VNQ) | 3.8% | 18.8% | 0.10 | 11.3% |
| Bitcoin (BTCUSD) | 11.6% | 55.3% | 0.41 | 10.0% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with RSSS | |
|---|---|---|---|---|
| RSSS | 9.6% | 48.5% | 0.47 | - |
| Sector ETF (XLP) | 7.6% | 14.7% | 0.38 | 4.2% |
| Equity (SPY) | 15.7% | 17.9% | 0.75 | 10.5% |
| Gold (GLD) | 13.0% | 16.0% | 0.67 | 1.9% |
| Commodities (DBC) | 7.8% | 17.9% | 0.35 | -1.0% |
| Real Estate (VNQ) | 5.5% | 20.7% | 0.23 | 12.6% |
| Bitcoin (BTCUSD) | 66.7% | 66.9% | 1.06 | 9.6% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 5/14/2026 | -11.8% | -16.6% | |
| 2/12/2026 | -0.4% | -2.4% | -8.4% |
| 11/13/2025 | 2.9% | -13.2% | -4.8% |
| 8/19/2025 | -1.0% | 2.8% | 28.9% |
| 5/8/2025 | 9.6% | 4.3% | -0.7% |
| 2/13/2025 | -7.4% | -17.9% | -25.8% |
| 11/14/2024 | 3.6% | 10.0% | 48.2% |
| 8/19/2024 | -1.1% | -4.9% | -6.7% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 7 | 7 | 7 |
| # Negative | 11 | 11 | 10 |
| Median Positive | 3.6% | 2.8% | 9.2% |
| Median Negative | -1.7% | -2.9% | -6.6% |
| Max Positive | 9.6% | 10.0% | 48.2% |
| Max Negative | -11.8% | -17.9% | -25.8% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 03/31/2026 | 05/15/2026 | 10-Q |
| 12/31/2025 | 02/13/2026 | 10-Q |
| 09/30/2025 | 11/14/2025 | 10-Q |
| 06/30/2025 | 09/19/2025 | 10-K |
| 03/31/2025 | 05/09/2025 | 10-Q |
| 12/31/2024 | 02/14/2025 | 10-Q |
| 09/30/2024 | 11/14/2024 | 10-Q |
| 06/30/2024 | 09/20/2024 | 10-K |
| 03/31/2024 | 05/13/2024 | 10-Q |
| 12/31/2023 | 02/12/2024 | 10-Q |
| 09/30/2023 | 11/14/2023 | 10-Q |
| 06/30/2023 | 09/15/2023 | 10-K |
| 03/31/2023 | 05/12/2023 | 10-Q |
| 12/31/2022 | 02/10/2023 | 10-Q |
| 09/30/2022 | 11/14/2022 | 10-Q |
| 06/30/2022 | 09/23/2022 | 10-K |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.